SND1 and neoplasm: Since the initial study from our group reported that SND1 is able to hijack nascent MHC-I heavy chain in tumor cells, thereby impairing the proper assembling of MHC-I and sensitizing tumor cells to a diminished immune surveillance with abolished antigen presentation to cytotoxic CD8+ T cells, large attention has been drawn to its importance in host immunity.